EcoDrugPlus

Dopamine Receptor D1

Ensembl ID : ENSFHEG00000007554
Gene Symbol: DRD1
2 Cross references
188 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSFHEG00000010585
Gene Symbol: DRD1B
1 Cross references
200 Possible Orthologues:

Dopamine Receptor D2

Ensembl ID : ENSFHEG00000006073
Gene Symbol: DRD2
3 Cross references
206 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSFHEG00000008249
Gene Symbol: DRD5
1 Cross references
158 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSFHEG00000013336
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl Nine Homolog 2

Ensembl ID : ENSFHEG00000016381
Gene Symbol: LOC105936554
2 Cross references
195 Possible Orthologues:

Egl Nine Homolog 3-Like

Ensembl ID : ENSFHEG00000003355
Gene Symbol: LOC105921426
3 Cross references
200 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 1

Ensembl ID : ENSFHEG00000000151
Gene Symbol: EGLN1
3 Cross references
213 Possible Orthologues:

Endothelial Pas Domain-Containing Protein 1-Like

Ensembl ID : ENSFHEG00000011885
Gene Symbol: LOC105933321
3 Cross references
211 Possible Orthologues:

Endothelin B Receptor-Like

Ensembl ID : ENSFHEG00000007093
Gene Symbol: LOC105921308
3 Cross references
201 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSFHEG00000012526
Gene Symbol: ECE1
3 Cross references
231 Possible Orthologues:

Endothelin Receptor Type A

Ensembl ID : ENSFHEG00000007975
Gene Symbol: EDNRA
2 Cross references
205 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).